comparemela.com
Home
Live Updates
Phase 1 2 Apex 01 Trial Nct04662580 - Breaking News
Pages:
Latest Breaking News On - Phase 1 2 apex 01 trial nct04662580 - Page 1 : comparemela.com
APEX-01 Looks to Add First PSMA-Directed ADC to Treatment Paradigm in mCRPC
John Shen, MD, discusses the phase 1/2 APEX-01 trial of ARX517 in metastatic castration-resistant prostate cancer.
Los angeles
United states
John shen
University of california
Worldj mens health
Los angeles health
During the european society for medical oncology
European society
Medical oncology
Preliminary efficacy
Worldj mens
Prostate cancer
Phase 1 2 apex 01 trial nct04662580
Antibody drug conjugate
Dr Pachynski on the Ongoing Investigation of ARX517 in Advanced Solid Tumors
Russell Pachynski, MD, discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 1/2 APEX-01 trial.
Russell pachynski
Siteman cancer center
Division of medical oncology
Washington university school of medicine
Medical oncology
Washington university school
Advanced solid tumors
Prostate cancer
Phase 1 2 apex 01 trial nct04662580
vimarsana © 2020. All Rights Reserved.